OS Therapies Inc (OSTX): Total Liabilities

Annual figures by period end, from SEC filings.

$11.86M
As of 2025-12-31
$24.01M
As of 2026-09-30
$24.81M2023-12-31: $24.81M2024-12-31: $4.73M2025-12-31: $11.86M$11.86M
2023-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$11.86M+151.0%2026-03-31, Balance as of period end
2024-12-31$4.73M-80.9%2026-03-31, Balance as of period end
2023-12-31$24.81Mn/a2025-03-31, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
OS Therapies Inc (OSTX)2025-12-31$11.86M+151.0%
Serina Therapeutics, Inc. (SER)2025-12-31$6.99M+12.4%
CV Sciences, Inc. (CVSI)2025-12-31$5.49M-10.4%
Azora Therapeutics, Inc. (AZR)2025-12-31$1.40M+43.1%
Cannapharmarx, Inc. (CPMD)2025-12-31$37.17M+21.3%
Kairos Pharma, Ltd. (KAPA)2024-12-31$992.0K-67.4%
Vyome Holdings, Inc (HIND)2025-12-31$2.74M-52.6%
Matinas BioPharma Holdings, Inc. (MTNB)2025-12-31$2.38M-52.9%
Telomir Pharmaceuticals, Inc. (TELO)2025-12-31$1.43M+109.7%

Compare OSTX, SER, CVSI, AZR side by side · Screen every company in Pharmaceutical Preparations ↗